Transient Liver Injury Associated With the Early Recovery of HCV-Specific T-Cell Responses and HCV Rebound in HIV-1/HCV Coinfected Patients Undergoing Highly Active Antiretroviral Therapy-Reference-Cited by-同舟云学术

Transient Liver Injury Associated With the Early Recovery of HCV-Specific T-Cell Responses and HCV Rebound in HIV-1/HCV Coinfected Patients Undergoing Highly Active Antiretroviral Therapy

Published:2013-02-01 Issue:2 Volume:62 Page:135-142
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Kang Fubiao,Chen Weiwei,Zhang Xinwei,Nie Weimin,Fu Junliang,Xu Xiangsheng,Zhao Peng,Zhang Xin,Li Wengang,Wang Fu-sheng,Zhang Zheng,Zhao Min

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference27 articles.

1. The challenge of hepatitis C in the HIV-infected person.;Thomas;Annu Rev Med,2008

2. . Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.;Graham;Clin Infect Dis,2001

3. . Low current and nadir CD4 T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study.;Rauch;Antivir Ther,2008

4. . Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.;Greub;Lancet,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Clinical Biomarkers Related to CD4 Recovery in HIV-Infected Patients—5-Year Observation;Viruses;2022-10-18

2. The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy;Clinical Immunology;2017-06

3. Increased proportions of dendritic cells and recovery of IFNγ responses in HIV/HCV co-infected patients receiving ART;Human Immunology;2016-01

4. Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy;Clinical Immunology;2014-12

5. Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients;Science Translational Medicine;2014-07-23